IRIDEX Corp (IRIX) stock
IRIXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends January 3
$0.70+0.01 (+1.72%)
Close on Nov 17, 2026Market cap $12.29MP/E –Yield –
Iridex r&d expenses
Research and development expenses are spending on new products and technology.
Iridex's R&D Expenses for the twelve months ending Oct 3, 2026 was $3.80M, down 0.7% year over year. For fiscal 2025 it was $3.67M, down 32.7% from the year before. Over ten years it grew -3.5% a year on average. The highest annual figure on record is $7.18M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $3.67M | -32.7% |
| FY2024 | Dec 28, 2024 | $5.45M | -20.2% |
| FY2023 | Dec 30, 2023 | $6.83M | -4.8% |
| FY2022 | Dec 31, 2022 | $7.18M | +4.5% |
| FY2021 | Jan 1, 2022 | $6.87M | +109.3% |
| FY2020 | Jan 2, 2021 | $3.28M | -10.9% |
| FY2019 | Dec 28, 2019 | $3.68M | -8.1% |
| FY2018 | Dec 29, 2018 | $4.01M | -23.1% |
| FY2017 | Dec 30, 2017 | $5.21M | -2.9% |
| FY2016 | Dec 31, 2016 | $5.37M | +2.9% |
| FY2015 | Jan 2, 2016 | $5.21M | +12.6% |
| FY2014 | Jan 3, 2015 | $4.63M | +25.7% |
| FY2013 | Dec 28, 2013 | $3.68M | -16.0% |
| FY2012 | Dec 29, 2012 | $4.39M | +12.1% |
| FY2011 | Dec 31, 2011 | $3.91M | +4.3% |
| FY2010 | Jan 1, 2011 | $3.75M | +13.2% |
| FY2009 | Jan 2, 2010 | $3.32M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Oct 3, 2026 | $1.01M | +4.3% |
| Q2 FY2026 | Jul 4, 2026 | $936.00K | +7.5% |
| Q1 FY2026 | Apr 4, 2026 | $905.00K | +3.3% |
| Q4 FY2025 | Jan 3, 2026 | $949.00K | -14.7% |
| Q3 FY2025 | Sep 27, 2025 | $972.00K | -25.2% |
| Q2 FY2025 | Jun 28, 2025 | $871.00K | -42.0% |
| Q1 FY2025 | Mar 29, 2025 | $876.00K | -43.0% |
| Q4 FY2024 | Dec 28, 2024 | $1.11M | -34.3% |
| Q3 FY2024 | Sep 28, 2024 | $1.30M | -15.7% |
| Q2 FY2024 | Jun 29, 2024 | $1.50M | -18.6% |
| Q1 FY2024 | Mar 30, 2024 | $1.54M | -12.2% |
| Q4 FY2023 | Dec 30, 2023 | $1.69M | +16.8% |
| Q3 FY2023 | Sep 30, 2023 | $1.54M | -8.7% |
| Q2 FY2023 | Jul 1, 2023 | $1.85M | -4.0% |
| Q1 FY2023 | Apr 1, 2023 | $1.75M | -17.3% |
| Q4 FY2022 | Dec 31, 2022 | $1.45M | -35.4% |
| Q3 FY2022 | Oct 1, 2022 | $1.69M | -5.6% |
| Q2 FY2022 | Jul 2, 2022 | $1.92M | +15.0% |
| Q1 FY2022 | Apr 2, 2022 | $2.12M | +81.6% |
| Q4 FY2021 | Jan 1, 2022 | $2.24M | +152.9% |
| Q3 FY2021 | Oct 2, 2021 | $1.79M | +105.8% |
| Q2 FY2021 | Jul 3, 2021 | $1.67M | +107.2% |
| Q1 FY2021 | Apr 3, 2021 | $1.17M | +62.0% |
| Q4 FY2020 | Jan 2, 2021 | $887.00K | +12.6% |
| Q3 FY2020 | Sep 26, 2020 | $869.00K | -13.7% |
| Q2 FY2020 | Jun 27, 2020 | $807.00K | -13.1% |
| Q1 FY2020 | Mar 28, 2020 | $719.00K | -24.9% |
| Q4 FY2019 | Dec 28, 2019 | $788.00K | -7.5% |
| Q3 FY2019 | Sep 28, 2019 | $1.01M | -12.4% |
| Q2 FY2019 | Jun 29, 2019 | $929.00K | +3.1% |
| Q1 FY2019 | Mar 30, 2019 | $958.00K | -13.2% |
| Q4 FY2018 | Dec 29, 2018 | $852.00K | -33.3% |
| Q3 FY2018 | Sep 29, 2018 | $1.15M | -13.0% |
| Q2 FY2018 | Jun 30, 2018 | $901.00K | -34.2% |
| Q1 FY2018 | Mar 31, 2018 | $1.10M | -17.6% |
| Q4 FY2017 | Dec 30, 2017 | $1.28M | -5.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.32M | – |
| Q2 FY2017 | Jul 1, 2017 | $1.37M | – |
| Q1 FY2017 | Apr 1, 2017 | $1.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.36M | – |
See a number that looks wrong?